The Neurona Therapeutics team (Credit: Neurona)
April 3, 2025 06:00 AM EDT
Financing
Startups
Cell/Gene Tx

Ex­clu­sive: Neu­rona bags $102M to treat epilep­sy with cell ther­a­py

Kyle LaHucik

Senior Reporter

A few cell and gene ther­a­py biotechs are do­ing al­right this week.

The lat­est is Neu­rona Ther­a­peu­tics, which ex­clu­sive­ly told End­points News that it col­lect­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Roche plans Phase 3 for its lat­est Alzheimer’s drug at­tempt af­ter un­veil­ing more ear­ly da­ta

DOJ at­tor­ney says Boehringer In­gel­heim has 'tremen­dous lever­age' in IRA ne­go­ti­a­tions

FDA ap­proves Am­gen's Up­liz­na in IgG4-re­lat­ed dis­ease

Trump has tout­ed Right to Try as a life­saver. Sev­er­al gov­ern­ment staff sup­port­ing it were just let go

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times